title: Cyclophosphamide plus vincristine and prednisone in the treatment of severe pemphigus vulgaris refractory to conventional therapy.
abstract: Five patients with severe pemphigus vulgaris refractory to conventional therapy with azathioprine and corticosteroids were treated with cyclophosphamide, vincristine and prednisone. One patient was not evaluable, while the remaining four patients showed a complete response. Duration of response was in the range of 13-94 months. Toxicity was mainly represented by alopecia, myelosuppression and gastrointestinal side-effects such as nausea/vomiting. Although cyclophosphamide and vincristine may induce severe side-effects, this association may be useful in controlling severe disease resistant to previous conventional therapies.
authors.affiliation: Section of Haematology, University of Palermo, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Citarrella
authors.forename: V
authors.initials: V
authors.lastname: Gebbia
authors.forename: P
authors.initials: P
authors.lastname: Di Marco
authors.forename: M
authors.initials: M
authors.lastname: Tambone Reyes
authors.forename: G
authors.initials: G
authors.lastname: Noto
authors.forename: M
authors.initials: M
authors.lastname: Aricò
mesh_terms: D000293:Adolescent; D000368:Aged; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010392:Pemphigus / Q000188:drug therapy*; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use*; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone